Page last updated: 2024-08-23

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Osteogenic Sarcoma

6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Osteogenic Sarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhanoa, A; Nathan, FM; Palanisamy, UD; Singh, VA1

Other Studies

1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Osteogenic Sarcoma

ArticleYear
Oxidative stress and antioxidant status in primary bone and soft tissue sarcoma.
    BMC cancer, 2011, Aug-27, Volume: 11

    Topics: Adolescent; Adult; Aged; Antioxidants; Bone Neoplasms; Case-Control Studies; Catalase; Child; Chromans; Humans; Malondialdehyde; Middle Aged; Osteosarcoma; Oxidative Stress; Protein Carbonylation; Sarcoma; Statistics, Nonparametric; Sulfhydryl Compounds; Superoxide Dismutase

2011